Skip to main content
Frederick DeRosier, DO, Internal Medicine, Raleigh, NC

FrederickJosDeRosierDO

Internal Medicine Raleigh, NC

Vice President, Rare Disease, Advanced Therapeutics, and Pediatrics, Labcorp, Inc.

Dr. DeRosier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. DeRosier's full profile

Already have an account?

  • Office

    Covance, Inc
    Raleigh
    Raleigh, NC 27614
    Phone+1 984-218-0142

Summary

  • More than 10 years of private practice experience (internal medicine) and nearly 19 years of clinical development experience in the pharmaceutical industry, primarily in neurosciences and rare diseases as global lead physician or program-level physician across multiple indications, and providing expertise on medical strategy, project feasibility and risk assessment and program execution.

Education & Training

  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1988 - 1991
  • St Clares Hospital Health Center
    St Clares Hospital Health CenterInternship, Preliminary Year, 1987 - 1988
  • NYIT College Of Osteopathic Medicine
    NYIT College Of Osteopathic MedicineClass of 1987

Certifications & Licensure

  • CT State Medical License
    CT State License 1989 - 2025

Publications & Presentations

PubMed

Other

  • Development of ISIS-TTRRx for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) 
    Frederick Derosier, Jesse Kwon, Elizabeth Ackerman, Erin Lettow, Mason Yamashita, Steven Hughes, Brett Monia, Neurology 84 (14 Supplement) 2015
    http://n.neurology.org/content/84/14_Supplement/S34.009
    Washington, DC - 4/22/2015

Professional Memberships

  • American Academy of Neurology
    Member

Industry Relationships

  • Executive Director, Clinical Sciences, Alexion Pharmaceuticals2015 - 2017
  • Executive Director, Clinical Development, Ionis Pharmaceuticals2014 - 2015
  • Executive Director, Neurosciences, Merz Pharmaceuticals2013 - 2014
  • Director, Neurosciences, GlaxoSmithKline2002 - 2013